Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now lists sponsor and collaborators (e.g., Washington University School of Medicine and NovoCure Ltd.) and adds links to essential documents (Study Protocol and Statistical Analysis Plan) plus related terminology, expanding the contextual resources for this trial.SummaryDifference50%

- Check15 days agoChange DetectedThe page's revision tag was updated to v3.6.5, replacing v3.6.4. This indicates a minor maintenance update to the page rather than a change to study content or eligibility details.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, signaling a new version of the page. This change represents an internal update to the page's versioning or display framework rather than a modification to the study data or eligibility details.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a small backend/content management update. There are no changes to the study data or displayed details.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page footer revision value updated from v3.6.0 to v3.6.2. This reflects a minor backend update to the page without changing content or user-facing data.SummaryDifference0.1%

- Check73 days agoChange DetectedRecruitment status is updated to no longer looking for participants, indicating the study is terminated or not enrolling. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention label was standardized to Intervention/Treatment.SummaryDifference0.6%

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.